Best Grants for Cancer Nonprofits in Hawaii

The Cancer Center Support Grants (CCSGs) aim to bolster NCI-Designated Cancer Centers through funding that supports diverse research activities. These grants enhance comprehensive, clinical, and basic cancer research while fostering collaboration among institutions. The program prioritizes interdisciplinary approaches to advance cancer prevention, diagnosis, and treatment, ultimately reducing cancer's impact on public health. CCSGs also facilitate resource sharing, administrative support, and the development of innovative research initiatives.

The ASTRO-AstraZeneca SCLC Therapy Challenge RFP aims to enhance research on limited-stage small cell lung cancer (LS-SCLC) through innovative combination therapies, particularly integrating immunotherapy with advanced radiation techniques. Proposals are encouraged to explore various aspects, including care patterns, treatment workflows, prognostic biomarkers, and toxicity management. The target budget for projects ranges from $175,000 to $375,000, with consideration given to higher requests based on scientific merit, fostering significant advancements in radiation oncology.

The RFA: Biology to Prevention Award (CRUK) aims to foster innovative translational research that enhances understanding of cancer biology, ultimately leading to effective prevention strategies. Joint applications from UK and US research teams are encouraged, with a focus on equal partnerships and complementary expertise. The funding provides up to £600,000 for UK costs and up to $946,000 for US costs, supporting projects of 1 to 5 years duration that address critical research questions in cancer prevention.

The Anna Fuller Fund Grant provides year-round support for organizations dedicated to alleviating suffering caused by cancer. Established in memory of Egbert C. Fuller’s wife, the fund prioritizes applications that focus on cancer research and education initiatives. Eligible applicants must be 501(c)(3) organizations or equivalent charities outside the U.S. Grant funds cannot be used for direct treatment, ensuring that resources are allocated to research and public education.

The James Paul Sutton Medical Research Fund Grant supports non-profit organizations engaged in cancer and medical research, established through a trust by the Sutton family. Eligible organizations must be 501(c)(3) exempt. Preference is given to cancer research initiatives, while grants are not available for individuals, political groups, or for-profit entities. This fund aims to sustain medical research efforts for the long term, continuing the legacy of the Sutton family.

The National Cancer Institute (NCI) plans to issue a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award in Clinical Oncology (K12). This program aims to enhance training for clinician-scientists in cancer research, fostering their career development and collaboration with basic research scientists. It mandates diverse oncology specialties in faculty, individualized career development plans, and mentorship, supporting Scholars for up to three years to promote their research initiatives in clinical trials.

The Simeon J. Fortin Charitable Foundation, founded in 1986, champions cancer research initiatives aimed at finding a cure. It supports relevant projects and fellowships within medical and research institutions, ensuring a significant impact on health-related research. The grant review process is conducted by The Medical Foundation, in coordination with the King Trust Postdoctoral Fellowships, enhancing collaboration and funding opportunities for innovative research in oncology.

The AGD Foundation Grant Program supports nonprofit organizations in the U.S. and Canada that provide free oral cancer screenings and education, particularly for underserved communities. Established in 1972, the AGD Foundation aims to enhance public oral health and raise awareness about oral/oropharyngeal cancer. By promoting early detection and education, the foundation seeks to improve survival rates and empower communities. Eligible applicants must be 501(c)(3) organizations demonstrating a commitment to community health.

The EMF SAMFund Financial Assistance Grants support young adult cancer survivors facing financial hardships due to their diagnosis. With 80,000 young adults diagnosed with cancer each year in the U.S., these grants provide critical assistance for essential living expenses like rent, car payments, and education. By prioritizing applicants who demonstrate financial need and articulate how the grant will aid their recovery, the program aims to alleviate financial toxicity and empower survivors to move forward with their lives.

The EMF Family Building Grants, offered by the Expect Miracles Foundation, support young adult cancer survivors in their fertility treatment and family-building efforts. These grants are designed for applicants with a clear family-building plan and financial strategy, helping bridge the gap in costs associated with fertility preservation, assisted reproductive technologies, and related services. By prioritizing those actively engaged in their journey, the foundation aims to empower survivors to pursue their dreams of family.

Individuals in Hawaii being treated for Waldenstrom macroglobulinemia can apply for Healthwell Foundation’s Waldenstrom Macroglobulinemia Fund, which awards up to US $8,000 for prescription drug copays and Medicare Part B insurance premiums. U.S.-treated, insured cancer patients within the foundation’s income guidelines may benefit, including those served by cancer-focused nonprofits.

Academic institutions and eligible nonprofits in Hawaii conducting translational cancer research on Fanconi anemia can apply for more than US $135,000 through the ACS – Fanconi Cancer Foundation Discovery Boost Grant. Grants from American Cancer Society help cancer and oncology researchers pursue high-risk, high-reward projects in early detection, prevention, and treatment for individuals with FA.

Underinsured patients being treated for mantle cell lymphoma in Hawaii and across the U.S. can receive up to US $8,500 toward prescription drug copays and Medicare Part B premiums. Grants from Healthwell Foundation help eligible cancer patients reduce out-of-pocket treatment costs when they have qualifying insurance and income within federal poverty guidelines.

Individuals in Hawaii being treated for chronic lymphocytic leukemia who are underinsured and have qualifying income can receive up to US $8,000 to offset prescription drug copays and Medicare Part B premiums. With a mission to reduce financial barriers to care, Healthwell Foundation supports U.S. patients needing help affording covered CLL medications.

Individuals in Hawaii receiving treatment in the U.S. for cancer-related behavioral health conditions can receive up to US $2,000 to cover prescription drug copays, counseling, psychotherapy, and related transportation costs. The Healthwell Foundation supports underinsured patients whose insurance covers part of their treatment and whose income falls within its federal poverty level guidelines.

Underinsured U.S. patients being treated for amyloidosis can receive up to US $8,000 to cover prescription drug copays and Medicare Part B premiums through the Amyloidosis Fund. Healthwell Foundation supports access to covered medications, which may benefit cancer-focused organizations in Hawaii assisting eligible patients with treatment-related costs.

Professional elderly blues musicians facing emergency medical or living expenses can receive US $500 in assistance for needs like doctor visits, transportation to treatments, home care, utilities, or burial costs. Pinetop Perkins Foundation provides this support nationwide, and Hawaii artists dealing with cancer or related health crises may be eligible if they meet income and age requirements.

Nonprofit and other eligible U.S.-recognized organizations conducting patient-centered cancer research can apply for up to US $13,000,000 to study comparative clinical effectiveness across the cancer care continuum. With a mission to improve healthcare decisions, Patient-Centered Outcomes Research Institute supports researcher–community partnerships addressing screening barriers, treatment quality, and survivorship needs, including work benefiting Hawaii communities.

Hawaii cancer and health research organizations conducting retrospective comparative clinical effectiveness studies can access funding through the Patient-Centered Outcomes Research Institute to improve patient-centered health decision making. Projects must leverage existing data sources and address at least one topic such as cancer, pain, maternal morbidity and mortality, mental and behavioral health, or rare diseases, with awards up to US $2,000,000.

Cancer research institutions and translational research centers in Hawaii and other U.S. jurisdictions can seek funding to advance organ-specific or biologically related cancer prevention, early detection, diagnosis, and treatment. National Institutes of Health SPORE P50 center grants support state-of-the-art, human biology–based translational projects that aim to reach a clinical endpoint within the grant period, including cross-cutting themes like pediatric cancers or epigenetics.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can receive tuition or professional development support, including certifications and conferences. Heart of Illinois Community Foundation offers this scholarship to eligible applicants residing in Macon, Moultrie, or Piatt County, with applications reviewed monthly through December 1, 2025.

Full-time radiation oncology faculty clinicians conducting cancer research, including those based in Hawaii, can seek multi-year career development support through the ASTRO-ACS Clinician Scientist Development Grant. Focused on cancer and radiation oncology, American Society for Radiation Oncology and American Cancer Society provide US $135,000 annually to help clinician scientists become independent investigators.

The Health Promotion and Disease Prevention Research Centers are offering supplemental funding for Special Interest Projects (SIPs) aimed at enhancing public health practices. These projects will focus on innovative health promotion and disease prevention strategies to mitigate leading health risks in the U.S. The initiative supports ten specific SIPs, including studies on cancer care, alcohol use reduction, and emergency preparedness, thereby fostering research that translates into real-world health improvements.

The National Cancer Institute (NCI) is set to release a Notice of Funding Opportunity (NOFO) aimed at advancing informatics technologies for cancer research. This initiative will support the development of tools that enhance data acquisition, management, and analysis throughout the cancer continuum. By focusing on technologies with proven impact, the NOFO seeks to optimize and sustain resources critical for cancer biology, diagnosis, treatment, and epidemiology.

Marion Community Foundation

Since 1998, area residents have been turning to Marion Community Foundation to make their philanthropic giving as effective as possible. We are a public charity serving thousands of people who share a common concern … improving the quality of life in Marion County. We use distributions from the more than 500 charitable funds — created by generous, local donors — to award more than $2.5 million in grants and scholarships each year to many of the humanitarian, educational and cultural organizations in this remarkable community we call home.

Marion Community Foundation is the area’s leading philanthropic organization, providing charitable donors the opportunity to easily create endowment funds to benefit and support our community through grants and scholarships. We serve communities throughout Marion County through philanthropy, leadership, and civic engagement.

Alex Cooper Memorial Scholarship

The Alex Cooper Memorial Scholarship Fund was created in 2017 by Jonathan Culler, his high school classmate and teammate, Andrea Ault, his devoted mother who never left his side, and the River Valley Class of 2017, after he lost a 3-year battle to childhood cancer, osteosarcoma.     

The Cooper Fund supports seniors and graduates from the River Valley Local Schools district. Alex’s scholarship gives special consideration to students active in River Valley athletics, especially football or baseball, and/or music. To honor Alex’s untimely passing, the Cooper Fund seeks to assist students who have been diagnosed with cancer personally, those with an immediate family member with the disease, and those who demonstrate financial need resulting from cancer treatment.

Rapid Cancer Grants

Fast Funding for Home Cancer Care Research

We fund healthcare researchers to rapidly explore the feasibility of home infusion as a solution to the ongoing challenges of capacity shortage, site of care management, and financial toxicity in cancer care.

Traditional funding pathways for new care models are too slow to impact patients, so we’ve streamlined the process. By providing funding approvals within 14 days, we enable healthcare teams to quickly launch and evaluate home-based cancer care programs that improve access and affordability.  

What can a Rapid Cancer Grant be used for?

Projects must comprise of research investigating the feasibility, safety, or economic benefit of cancer care at home and must include delivering care to patients via an IRB approved study. IRB approval may be obtained after grant approval. Projects may include assessing suitability of home infusion, enabling access to lab draws at home, or remote care co-ordination to reduce time toxicity for patients.

If you’re a healthcare worker at an oncology practice, hospital or academic institution in the United States and are interested in continuing or launching a new home cancer care initiative, we invite you to apply for a Rapid Cancer Grant.

We are Revolutionaries

Who We Are

We are Revolutionaries -passionate in our singular pursuit of discovering, developing and delivering innovative targeted therapies for patients living with RAS-addicted cancer. At Revolution Medicines, we believe in challenging the status quo to find new therapeutic approaches to some of the toughest cancers. With our first wave of investigational RAS(ON) inhibitors, we are pioneering a new way of targeting the RAS cancer drivers of disease, and we have the potential to change the treatment paradigm in these cancers where there is a significant unmet medical need.

Our mission is to revolutionize treatment for patients with RAS-addicted cancers through the discovery, development and delivery of innovative, targeted medicines.

Research, Grants & Support

At Revolution Medicines, we understand the importance of extending our support of scientific advancement beyond the research we conduct and the medicines we provide.

We support activities that make meaningful information and resources available to the broader medical and scientific communities to help advance science, increase understanding of certain diseases, and enhance patient care.

Charitable Donations

Funding for programs that deliver disease awareness, treatment education, or other healthcare information intended to improve patient understanding and empowerment.